Polyclonal Rabbit anti-Human SLC5A11 / SMIT2 Antibody (WB)
Catalog Number: LS-C748223
2 sizes / from $281.00
Antibody: Rabbit Polyclonal
Applications: Immunohistochemistry (general), Western Blot
Reactivity: Human, Mouse, Rat
Format: Liquid
Anti-Murine LIX (CXCL6) Western Blot Reduced
Polyclonal Rabbit anti-Mouse CXCL5 Antibody (WB)
Primary AntibodyLSBio Guarantee
| Antibody: | Rabbit Polyclonal |
| Applications: | Enzyme-Linked Immunosorbent Assay, Western Blot |
| Reactivity: | Mouse |
| Format: | Lyophilized |
$364.00each
Catalog Number: LS-C104413-50
Catalog Number: LS-C104413
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- CXCL5 antibody LS-C104413 is an unconjugated rabbit polyclonal antibody to mouse CXCL5. Validated for ELISA and WB. Cited in 1 publication.
- Application
- ELISA, WB
- Reactivity
- Ms
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Polyclonal Antibodies
- Alternative Names
- C-X-C motif chemokine 5 | CXCL5 | ENA-78(1-78) | GCP-2 | ENA78 | SCYB5 | ENA-78 | Small inducible cytokine B5 | Small-inducible cytokine B5 | LIX | AMCF-II
- UniProt Number
- P42830
- NCBI GenBank
- NM_002994 | NP_002985.1
- SwissProt
- P42830
Target
- Target
- Mouse CXCL5
- Antigen Species
- Mouse
- Epitope
- Mouse LIX
- Gene Name
- CXCL5
Antibody
- Host Species
- Rabbit
- Clonality
- Polyclonal
Immunogen
- Immunogen
- E.coli derived recombinant Murine LIX.
- Immunogen Type
- Recombinant Immunogen
Format
- Conjugate/Label
- Unconjugated
- Format
- Lyophilized
- Formulation
- Lyophilized from PBS, pH 7.2
- Preservative
- No
- Purification Method
- Affinity Purified
Storage & Handling
- Storage Conditions
- Store Lyophilized at room temperature up to 1 month; Reconstituted for up to 2 weeks at 2°C to 8°C. Aliquot and freeze at -20°C for long term storage. Avoid freeze/thaw cycles.
- Recommended Storage Buffer
- PBS
Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy. Nicholas C DeVito, Michael Sturdivant, Balamayooran Thievanthiran, Christine Xiao, Michael P Plebanek, April K S Salama, Georgia M Beasley, Alisha Holtzhausen, Veronica Novotny-Diermayr, John H Strickler, Brent A Hanks. Cell reports. 2021 May;35:109071. PubMed: 33951424 PMC: PMC8148423
